Search Results 231-240 of 16066 for pharmacogenetics

  1. Resources - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...

  2. Individualized Medicine - 2015 Archives - Mayo Clinic News Network

    While some would like to drape the mantle "The father of pharmacogenomics" on Richard Weinshilboum, M.D., the scientist parries: "The only thing that I'm father ...

  3. Laboratory Services - Center for Individualized Medicine - Mayo Clinic Research

    The Center for Individualized Medicine's laboratory services offer resources, expertise and support to investigators at Mayo Clinic, at other research ...

  4. A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer - Mayo Clinic

    This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...

  5. Publications - Ethylin W. Jabs, M.D. - Mayo Clinic

    Evidence of gene-environment interaction for two genes on chromosome 4 and environmental tobacco smoke in controlling the risk of nonsyndromic cleft palate.

  6. A Study to Develop a Pulmonary Hypertension Association Registry (PHAR) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study to Evaluate Intact FGF23 Performance in Patients with Tumor-induced Osteomalacia (TIO) and X-linked Hypophosphatemia (XLH) - Mayo Clinic

    The purpose of this study is to establish the clinical performance of the Medfrontier Intact FGF23 immunoassay in patients with tumor induced osteomalacia (TIO) ...

  9. A Study of Biofluids in Parkinson Disease and Related Disorders - Mayo Clinic

    The purpose of this study is to analyze DNA and genome-wide analyses, as well as metabolomics and biomarker studies, from patients in the spectrum clinically ...

  10. Toxicology and Pharmacology Shared Resource - Department of Molecular Medicine - Mayo Clinic Research

    The Department of Molecular Medicine at Mayo Clinic provides endotoxin analysis, CBC, virus and gene therapy, toxicology, and pharmacology services.